Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Vaccination

NCT01983540 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

558

Enrollment

INDUSTRY

Sponsor class

Conditions

Diphtheria
Tetanus
Whooping Cough
Hepatitis B
Poliomyelitis
Haemophilus Influenzae Type b

Interventions

BIOLOGICAL: DTaP-IPV-Hep B- PRP~T + Prevenar + Rotarix vaccine
BIOLOGICAL: DTaP- IPV-Hep B-PRP~T + Prevenar + Rotarix + Infanrix hexa vaccine
BIOLOGICAL: Infanrix hexa + Prevenar + Rotarix vaccine

Sponsor

Sanofi Pasteur, a Sanofi Company